James J Loughlin's Net Worth

$9.37 Million

Estimate Recalculated Sep 8, 2024 07:26PM EST

Who is James J Loughlin?

James J Loughlin has an estimated net worth of $9.37 Million. This is based on reported shares across multiple companies, which include ALFACELL CORP, InspireMD, Inc., Edge Therapeutics, Inc., CELGENE CORP /DE/, and DATASCOPE CORP.

SEC CIK

James J Loughlin's CIK is 0001276550

Past Insider Trading and Trends

2015 was James J Loughlin's most active year for acquiring shares with 13 total transactions. James J Loughlin's most active month to acquire stocks was the month of May. 2019 was James J Loughlin's most active year for disposing of shares, totalling 21 transactions. James J Loughlin's most active month to dispose stocks was the month of May. 2018 saw James J Loughlin paying a total of $1,084,192.50 for 84,795 shares, this is the most they've acquired in one year. In 2016 James J Loughlin cashed out on 85,518 shares for a total of $3,356,402.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALFACELL CORP No price found

Investor

James J Loughlin owns 10,000 units of Common Stock. In the year 2004 James J Loughlin filed a total of 10 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Dec 31
Form 4
+300.00%
7.5K
$2.04
$15,267.80
10K
Jul 25
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Dec 31
Form 4
∞
2.5K
$4.54
$11,360.00
2.5K
Sep 21 - Sep 22
Form 4
—
0
—
—
0
Jan 14
Form 3
—
0
—
—
0
No matching records found

InspireMD, Inc. (NSPR) Snapshot price: $2.8

Investor

James J Loughlin owns 51,501 units of Common Stock which is worth $144,202.80. In the year 2012 James J Loughlin filed a total of 12 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3,331.11%
50K
$0.59
$29,500.00
51.5K
Mar 21
Form 4
+0.07%
1
—
—
1.5K
Jan 26
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
May 9
Form 4
∞
15K
$2.00
$30,000.00
15K
Apr 16
Form 4
—
0
—
—
0
Sep 21
Form 3
—
0
—
—
0
No matching records found

Edge Therapeutics, Inc. (PDSB) Snapshot price: $2.91

Investor

James J Loughlin owns 26,625 units of Common Stock which is worth $77,478.75. In the year 2015 James J Loughlin filed a total of 10 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 28
Form 4
+60.15%
10K
—
—
26.63K
Mar 15
Form 4
—
0
—
—
0
Aug 14
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 20
Form 4
+100.00%
3K
$9.24
$27,720.00
6K
Mar 6
Form 4
—
0
—
—
0
Jun 21
Form 4
∞
3K
$7.63
$22,901.43
3K
Mar 11
Form 4
∞
19.63K
$10.88
—
19.63K
Oct 6
Form 3
—
0
—
—
0
No matching records found

CELGENE CORP /DE/ No price found

Investor

James J Loughlin used to own units in Common Stock but no longer holds any shares there. In the year 2007 James J Loughlin filed a total of 40 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-43.66K
—
—
0
Nov 20
Form 4
+8.35%
3.23K
—
—
41.86K
Jun 13 - Jun 15
Form 4
—
0
—
—
0
Jun 3
Form 4
+3.21%
1.2K
$54.88
-$1,494,078.65
38.64K
Feb 7
Form 4
+0.90%
334
—
—
37.44K
Jun 17
Form 4
+7.98%
2.74K
—
—
37.1K
Jun 13 - Jun 15
Form 4
+41.05%
10K
$54.49
-$568,762.50
34.36K
Jun 4
Form 4
—
0
$59.60
-$599,677.50
24.36K
Mar 12
Form 4
+3.11%
734
—
—
24.36K
Jul 1
Form 4
—
0
$81.50
-$1,926,682.50
23.63K
Scheduled
Jun 26
Form 4
+1.43%
333
—
—
23.63K
Jun 17
Form 4
+1.64%
375
—
—
23.29K
Jun 14 - Jun 15
Form 4
—
0
$76.48
-$879,120.00
22.92K
May 1
Form 4
—
0
$70.23
-$2,412,900.00
22.92K
Aug 23
Form 4
+3.30%
733
—
—
22.92K
Jul 1
Form 4
+1.52%
333
—
—
22.19K
Jun 15 - Jun 17
Form 4
+10.45%
2.07K
—
—
21.85K
Jun 12
Form 4
-9.60%
-2.10K
$104.12
-$218,652.00
19.79K
Feb 22
Form 4
+3.47%
733
—
—
21.89K
Jul 1
Form 4
—
0
—
—
0
Jun 17
Form 4
+24.29%
4.13K
—
—
21.15K
Jun 12 - Jun 13
Form 4
—
0
$59.95
-$1,252,000.00
17.02K
Aug 22
Form 4
—
0
—
—
0
Jul 1
Form 4
+32.07%
2.07K
—
—
8.51K
Jun 12 - Jun 13
Form 4
+34.19%
1.72K
—
—
6.74K
Jun 13 - Jun 16
Form 4
—
0
—
—
0
Jun 12
Form 4
+13.56%
600
$60.29
$36,174.00
5.03K
Jun 22
Form 4
+44.84%
1.37K
—
—
4.42K
Jun 16 - Jun 17
Form 4
—
0
—
—
0
Jun 13
Form 4
+81.31%
1.37K
—
—
3.06K
Jun 15 - Jun 17
Form 4
+68.50%
685
—
—
1.69K
Jun 16 - Jun 17
Form 4
—
0
—
—
0
Jun 17
Form 4
+60.00%
600
$39.57
$23,742.00
1.6K
May 6
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Mar 17
Form 4
—
0
—
—
0
Dec 17
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Jan 8
Form 3
—
0
—
—
0
No matching records found

DATASCOPE CORP No price found

Investor

James J Loughlin owns 1,000 units of Common Stock par value $.01 per share. James J Loughlin used to own units in Common Stock but no longer holds any shares there. In the year 2004 James J Loughlin acquired a total of 1,000 shares in DATASCOPE CORP at a cost of $29,800.00, James also disposed a total of 1,000 shares of DATASCOPE CORP equalling to $53,000.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.00K
$53.00
-$53,000.00
0
Jan 30
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 1
Form 4
∞
1K
$29.80
$29,800.00
1K
May 19
Form 4
—
0
—
—
0
Jan 1
Form 3
—
0
—
—
0
No matching records found